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The continuing debate about the use of human embryonic stem
cell research
T
here is a growing consensus among
scientists worldwide that human
embryonic stem (hES) cell research
will lead to the development of thera-
pies for common diseases or conditions
that affect millions of people, including
neurological disease or injury, diabetes,
and myocardial infarction. hES cells are
also valuable tools in understanding
early human developmental processes,
cell division and differentiation
mechanisms, drug discovery and toxi-
city testing, and for developing models
of human diseases. At the same time
many individuals profess to be outraged
by the prospect of using human
embryos for research and therapeutic
purposes and some countries or states
have declared such research to be
unethical and have banned it. Many
people also think it would be immoral to
benefit from what they consider to be
evil.
Obviously all those who think hES
cell research is immoral will wish to
ensure not only that no hES cell
therapies are developed but that they
will not openly or inadvertently benefit
from such therapies when they can
avoid it. I have accordingly designed
the following Advance Directive (fig 1)
and here offer it as a service to all those
offended by therapeutic and research
use of human embryos.
The design of this advance directive to
protect embryos highlights an important
point that is often overlooked, namely
that those who object to hES cell
research as unethical and block such
research are committed in consistency
to the rejection of any benefits or
therapies, which may flow from such
research. It is questionable whether
these people will fully accept this con-
sequence of opposition to hES cell
research, and whether this rejection of
hES cell research will be practically
possible. (Once stem cell therapies have
been developed and stem cell research is
conducted worldwide it will be very
difficult, if not impossible, for practicing
physicians to know whether a drug or
therapy was or was not developed
through hES cell research).
We, and especially policymakers,
should keep in mind that very often
there is a significant difference between
what people say that they believe—that
is their professed beliefs, and their actual
beliefs revealed by their actions. It does
not follow from the fact that people
claim that embryos should be protected
as if they are persons, that those same
individuals will follow through and do
everything necessary to ensure that in
fact this protection is implemented. In
most countries with restrictive legisla-
tion on the use of embryos, intrauterine
devices, and the ‘‘morning after’’ pill,
abortion without medical indication and
IVF are generally accepted practices. In
all these practices embryos are created
and sacrificed for purposes regarded as
important and beneficial. Likewise, it is
to be expected that if therapies were to
be proven for serious illnesses, using
hES cells, many people objecting to hES
cell research now will not refuse such
treatments when they or their loved
ones are suffering or dying from a
disease for which no other treatment is
available. The same can be expected at
the level of policy. Will societies that
continue to ban or severely restrict hES
cell research deny any such treatments
to their citizens? This is very unlikely. Of
course there will be some individuals
who will refuse treatments based on
embryo research or products derived
from embryos. Just as there are people
who, based on their deeply held beliefs,
refuse euthanasia while suffering terri-
bly from a terminally illness, and
women who refuse to undergo abortion,
which would save their own life, to
protect the life of their foetus (like
Gianna Molla who, while she was
pregnant, was diagnosed with a large
cyst in her womb, which required
surgery and abortion of the fetus. She
refused abortion and the child was born
healthy, but Gianna died 7 days later.
She is now regarded as the martyr and
patroness of pro-life and anti-abortion
movements).
Here we come to a second reason for
designing this advance directive. In a
democracy it is not the opinion of the
majority alone that determines public
policy and regulations, nor should
minorities close all the options down
for their fellow citizens. The core values
in a democracy are freedom and toler-
ance. As pointed out before, it is to be
expected that only a significant minority
will actually bring their professed beliefs
into practice. When such beliefs are so
at odds with self interest and the public
good, why would such a minority have
the right to block all the options for
their fellow citizens? There is no agree-
ment about what moral status to accord
to an embryo, and there never will be.
Looking for consensus or complex com-
promises that satisfy neither of the
moral positions requires considerable
effort and slows down important life
saving research. It is time to look for
better ways of dealing with the vested
Figure 1 Advance Directive.
The version of this article published in the
September issue of the Journal of Medical
Ethics is missing a figure. This article therefore
replaces the previously incorrect version.
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interests and entrenched positions in
hES cell research, and we should do this
in accordance with democratic values,
that is, whilst maintaining a maximum
degree of choice for citizens.
Respect for minority views can be
shown by not imposing choices on them
which they consider ethically unaccep-
table. If people who accord very high
value to embryos refuse to benefit from
the results of hES cell research, they
should have the possibility to do so. But
tolerance should not go in one direction
only. Options open to some citizens
should not be constrained because of
deeply held, often religiously based
views of others. These minorities should
also tolerate the views and wishes of all
their fellow citizens who want to have
their lives and the lives of their loved
ones saved with treatments based on
hES cell research or products derived
from embryos. However, the problem
goes beyond the issue of minority versus
majority. Freedom of research is one of
the most important rights and moral
values in a democracy. It is not an
absolute value and can be restrained by
other important values such as the
safety and respect for research partici-
pants and patients. However, in the
context of hES cell research, the appli-
cation of the principle depends greatly
on the moral status of the embryo. A
justification primarily based on a con-
tested value is insufficient to restrict
freedom of research to such a consider-
able extent.
The way forward in the stem cell
debate and, accordingly, stem cell pol-
icymaking is to recognise that most
people accord a relative moral status to
the human embryo and are prepared to
accept the creation and sacrifice of
embryos for purposes considered as very
important, such as life-saving therapies.
Most people accord high value to
embryos when these are included in a
parental project, that is, when people
create embryos to start a family, but in
most cases (in IVF treatments), this
value decreases when the family is
completed and the embryos are ‘‘left-
over’’. Those who don’t share this view-
point should, to the extent possible,
have the choice not to benefit from hES
cell therapies and they should have the
freedom to defend their case—for exam-
ple, by proving that there are equally
effective alternatives that do not require
the use of embryos. Stem cell therapies
will surely be developed in the not too
distant future. Focusing on a minority
view on the moral status of embryos
may crystallise both the issues and the
sincerity of the participants in this
crucial contemporary debate. We risk
neglecting other issues that may be far
more important to most citizens, includ-
ing their safety and privacy, and their
access to life-saving drugs and thera-
pies. If we really do care about human
lives, then we should not continue to be
hostages of a particular viewpoint on
the moral status of the embryo, but we
should start to focus on these other
issues. The proposed advance directive is
meant to dramatise the consequences of
consistently holding a particular moral
view and to stimulate discussion about
how the debate should proceed.
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